Insider Transactions in Q2 2025 at Bio Rad Laboratories, Inc. (BIO)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 24
2025
|
Courtney C Enloe EVP, General Counsel & Sec |
SELL
Payment of exercise price or tax liability
|
Direct |
67
-34.18%
|
$16,683
$249.74 P/Share
|
|
Apr 24
2025
|
Courtney C Enloe EVP, General Counsel & Sec |
BUY
Exercise of conversion of derivative security
|
Direct |
186
+48.69%
|
-
|
|
Apr 24
2025
|
Roop Kalyan Lakkaraju EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
386
-31.36%
|
$96,114
$249.74 P/Share
|
|
Apr 24
2025
|
Roop Kalyan Lakkaraju EVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,077
+46.66%
|
-
|
|
Apr 22
2025
|
Melinda Litherland Pei Director |
BUY
Exercise of conversion of derivative security
|
Direct |
308
+50.0%
|
-
|
|
Apr 22
2025
|
Arnold A Pinkston Director |
BUY
Exercise of conversion of derivative security
|
Direct |
308
+50.0%
|
-
|
|
Apr 22
2025
|
Jeffrey L Edwards Director |
BUY
Exercise of conversion of derivative security
|
Direct |
308
+50.0%
|
-
|
|
Apr 22
2025
|
Gregory K Hinckley Director |
BUY
Exercise of conversion of derivative security
|
Direct |
308
+50.0%
|
-
|